| 英文别名 |
LOXO195;Selitrectinib;0J45910S3X;selitrectinib (proposed INN);LOXO 195;GTPL10314;example 28 [WO2017075107A1];Unii-0J45910S3X;(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo(1,5-a)pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one;NSC-809970;AKOS037648883;12H-5,7-ETHENOPYRAZOLO(3,4-D)PYRIDO(2,3-K)PYRROLO(2,1-M)(1,3,7)TRIAZACYCLOTRIDECIN-12-ONE, 5-FLUORO-1,2,3,3A,8,9,10,11-OCTAHYDRO-10-METHYL-, (3AR,10R)-;EX-A1873;TRK Inhibitor LOXO-195;(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one;BDBM50507492;CS-0022378;DB14896;CHEMBL4297627;AC-32662;(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexaazapentacyclo(16.5.2.0^(2,6).0^(7,12).0^(21,25))pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one;(22R,6R)-35-FLUORO-6-METHYL-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-3(3,2)-PYRIDINA-2(1,2)-PYRROLIDINACYCLOOCTAPHAN-8-ONE;(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexazapentacyclo(16.5.2.02,6.07,12.021,25)pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one;SCHEMBL18823882;9-Fluoro-15-methyl-2,11,16,20,21,24-hexaazapentacyclo(16.5.2.02,6.07,12.021,25)pentacosa-1(24),7,9,11,18(25),19,22-heptaen-17-one;BAY-2731954;HY-101977;(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexaazapentacyclo[16.5.2.0,.0,.0,pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one;DA-67532;example 28 (WO2017075107A1);SELITRECTINIB [INN];selitrectinibum;NSC809970;(3aR,10R)-5-Fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-12H-15,17-Ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one,;2097002-61-2;12H-15,17-Ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one, 5-fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-, (3aR,10R)-;Selitrectinib (LOXO-195);BAY 2731954;XID00261;(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one;LOXO-195;Cas registry number 2097002-61-2 ~1~1 C20 H21 F N6 O 10H-5,7-ethenopyrazolo(3,4-d)pyrido(2,3-k)pyrrolo(2,1-m)(1,3,7)triazacyclotridecin-10-one, 17-fluoro-1,2,3,11,12,13,14,18b-octahydro-12-methyl-, (12R,18bR)-;LOXO 195(Selitrectinib);(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexaazapentacyclo[16.5.2.0^{2,6}.0^{7,12}.0^{21,25}]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one;SelitrectinibLOXO-195;SELITRECTINIB [WHO-DD];(3aR,10R)-5-Fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-12H-15,17-ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one;(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexaazapentacyclo[16.5.2.0(2),?.0?,(1)(2).0(2)(1),(2)?]pentacosa-1(24),7,9,11,18(25),19,22-heptaen-17-one;BS-15941 |
微信公众号
客服
